Literature DB >> 26902209

The First Fatal Case of Crimean-Congo Hemorrhagic Fever Caused by the AP92-Like Strain of the Crimean-Congo Hemorrhagic Fever Virus.

Mostafa Salehi-Vaziri1, Vahid Baniasadi, Tahmineh Jalali, S Maryam Mirghiasi, Sanam Azad-Manjiri, Roya Zarandi, Tahereh Mohammadi, Sahar Khakifirouz, Mehdi Fazlalipour.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26902209     DOI： 10.7883/yoken.JJID.2015.533

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN： 1344-6304            Impact factor:   1.362


× No keyword cloud information.
  10 in total

1.  Molecular detection of Crimean-Congo hemorrhagic fever virus in ticks, Greece, 2012-2014.

Authors:  Anna Papa; Anastasia Kontana; Katerina Tsioka; Ilias Chaligiannis; Smaragda Sotiraki
Journal:  Parasitol Res       Date:  2017-09-17       Impact factor: 2.289

2.  The host inflammatory response contributes to disease severity in Crimean-Congo hemorrhagic fever virus infected mice.

Authors:  Joseph W Golden; Xiankun Zeng; Curtis R Cline; Jeffrey M Smith; Sharon P Daye; Brian D Carey; Candace D Blancett; Charles J Shoemaker; Jun Liu; Collin J Fitzpatrick; Christopher P Stefan; Aura R Garrison
Journal:  PLoS Pathog       Date:  2022-05-19       Impact factor: 7.464

3.  Combination of RT-PCR and proteomics for the identification of Crimean-Congo hemorrhagic fever virus in ticks.

Authors:  Isabel G Fernández de Mera; Ilias Chaligiannis; Angélica Hernández-Jarguín; Margarita Villar; Lourdes Mateos-Hernández; Anna Papa; Smaragda Sotiraki; Francisco Ruiz-Fons; Alejandro Cabezas-Cruz; Christian Gortázar; José de la Fuente
Journal:  Heliyon       Date:  2017-07-12

4.  Generic amplification and next generation sequencing reveal Crimean-Congo hemorrhagic fever virus AP92-like strain and distinct tick phleboviruses in Anatolia, Turkey.

Authors:  Ender Dinçer; Annika Brinkmann; Olcay Hekimoğlu; Sabri Hacıoğlu; Katalin Földes; Zeynep Karapınar; Pelin Fatoş Polat; Bekir Oğuz; Özlem Orunç Kılınç; Peter Hagedorn; Nurdan Özer; Aykut Özkul; Andreas Nitsche; Koray Ergünay
Journal:  Parasit Vectors       Date:  2017-07-14       Impact factor: 3.876

Review 5.  Animal Models for Crimean-Congo Hemorrhagic Fever Human Disease.

Authors:  Aura R Garrison; Darci R Smith; Joseph W Golden
Journal:  Viruses       Date:  2019-06-28       Impact factor: 5.048

Review 6.  Current status of Crimean-Congo haemorrhagic fever in the World Health Organization Eastern Mediterranean Region: issues, challenges, and future directions.

Authors:  Seif S Al-Abri; Idris Al Abaidani; Mehdi Fazlalipour; Ehsan Mostafavi; Hakan Leblebicioglu; Natalia Pshenichnaya; Ziad A Memish; Roger Hewson; Eskild Petersen; Peter Mala; Tran Minh Nhu Nguyen; Mamunur Rahman Malik; Pierre Formenty; Rosanna Jeffries
Journal:  Int J Infect Dis       Date:  2017-03-01       Impact factor: 3.623

7.  Evaluation of Crimean-Congo Hemorrhagic Fever Orthonairovirus AviTagged Nucleoprotein for Potential Application in Diagnosis

Authors:  Tahmineh Jalali; Mostafa Salehi-Vaziri; Mohammad Hassan Pouriayevali; Seyed Latif Mousavi Gargari
Journal:  Iran Biomed J       Date:  2019-05-20

Review 8.  Structural and functional similarities in bunyaviruses: Perspectives for pan-bunya antivirals.

Authors:  Sebastiaan Ter Horst; Nádia Conceição-Neto; Johan Neyts; Joana Rocha-Pereira
Journal:  Rev Med Virol       Date:  2019-02-11       Impact factor: 6.989

9.  Interactions of Human Dermal Dendritic Cells and Langerhans Cells Treated with Hyalomma Tick Saliva with Crimean-Congo Hemorrhagic Fever Virus.

Authors:  Sergio E Rodriguez; Alexander J McAuley; Aysen Gargili; Dennis A Bente
Journal:  Viruses       Date:  2018-07-20       Impact factor: 5.048

10.  A single mutation in Crimean-Congo hemorrhagic fever virus discovered in ticks impairs infectivity in human cells.

Authors:  Christina Spiropoulou; Sandra Junglen; Éric Bergeron; Brian L Hua; Florine Em Scholte; Valerie Ohlendorf; Anne Kopp; Marco Marklewitz; Christian Drosten; Stuart T Nichol
Journal:  Elife       Date:  2020-10-21       Impact factor: 8.140
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.